MCK * Stock Overview
Provides healthcare services in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
McKesson Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10,192.00 |
| 52 Week High | US$11,470.00 |
| 52 Week Low | US$8,649.60 |
| Beta | 0.44 |
| 11 Month Change | 1.06% |
| 3 Month Change | n/a |
| 1 Year Change | 30.15% |
| 33 Year Change | 124.74% |
| 5 Year Change | 275.40% |
| Change since IPO | 922.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| MCK * | MX Healthcare | MX Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | -0.3% |
| 1Y | 30.1% | -15.0% | -4.0% |
Return vs Industry: MCK * exceeded the MX Healthcare industry which returned -15% over the past year.
Return vs Market: MCK * exceeded the MX Market which returned -4% over the past year.
Price Volatility
| MCK * volatility | |
|---|---|
| MCK * Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in MX Market | 6.2% |
| 10% least volatile stocks in MX Market | 2.7% |
Stable Share Price: MCK *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine MCK *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1833 | 48,000 | Brian Tyler | www.mckesson.com |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International.
McKesson Corporation Fundamentals Summary
| MCK * fundamental statistics | |
|---|---|
| Market cap | Mex$1.62t |
| Earnings (TTM) | Mex$51.94b |
| Revenue (TTM) | Mex$6.76t |
31.2x
P/E Ratio0.2x
P/S RatioIs MCK * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCK * income statement (TTM) | |
|---|---|
| Revenue | US$330.19b |
| Cost of Revenue | US$317.29b |
| Gross Profit | US$12.89b |
| Other Expenses | US$10.36b |
| Earnings | US$2.54b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 19.98 |
| Gross Margin | 3.90% |
| Net Profit Margin | 0.77% |
| Debt/Equity Ratio | -208.9% |
How did MCK * perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield13%
Payout RatioDoes MCK * pay a reliable dividends?
See MCK * dividend history and benchmarks| McKesson dividend dates | |
|---|---|
| Ex Dividend Date | Dec 02 2024 |
| Dividend Pay Date | Jan 02 2025 |
| Days until Ex dividend | 7 days |
| Days until Dividend pay date | 38 days |
Does MCK * pay a reliable dividends?
See MCK * dividend history and benchmarks